GLP-one receptor agonists like Semaglutide and Tirzepatide have shown important cardiovascular Advantages, together with diminished danger of key adverse cardiovascular occasions (MACE) for example coronary heart attack and stroke44. Though less common, more serious side effects can occur. These include pancreatitis, which presents as severe